Allele Biotechnology & Pharmaceuticals, Inc. — Form D
Allele Biotechnology & Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-26. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-10-26
- Form: D
- Accession: 0001617865-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $11.0M
- Investors: 4
- Date of first sale: 2016-10-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-273224
Issuer
- Name: Allele Biotechnology & Pharmaceuticals, Inc.
- CIK: 0001617865
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 6404 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Phone: 858-587-6645
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Quishi Fu | Director | San Diego, CA |
| Robert LaPolla | Director | San Diego, CA |
| Shao-Chung Tsai | Director | San Diego, CA |
| Jiwu Wang | Director | San Diego, CA |
| Jiwu Wang | Executive Officer | San Diego, CA |
| Lin Yang | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More